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Research
AbstrACt
Objectives The aim of this study was to critically explore 
the views of the public about the acceptability and 
feasibility of proactive approaches to earlier dementia 
diagnosis and also identification of people at high risk of 
dementia.
Design Qualitative study using task group methodology 
and thematic data analysis.
setting Task groups were held either at the university 
(n=5) or at a carers’ centre (n=1). Participants: A 
convenience sample of 31 of 54 participants identified 
by local non-statutory agencies took part in a task group. 
All were aged between 40 years and 80 years, 21 were 
women and 10men participated.
results Despite the use of task group methodology, 
participants expressed limited understandings of 
dementia and confusion between proactive approaches. 
Nevertheless, they highlighted a range of potential benefits 
and limitations of proactive approaches and the ethical 
issues raised. There was a preference to embed risk 
assessment within routine health checks, which focused 
on achieving a healthier lifestyle, rather than specifically 
on dementia. Participants emphasised the need to ensure 
informed consent prior to use of proactive approaches 
and to provide appropriate support. They also suggested 
alternative approaches that could potentially facilitate the 
early detection of dementia or reduce risk at a population 
level.
Conclusions As international policy on dementia shifts 
towards a prevention agenda there is growing interest 
in identifying those at risk of developing dementia. This 
study provides useful insights into the acceptability of 
the use of such proactive approaches among the public. 
The introduction of proactive approaches to dementia 
identification raises complex practical and ethical issues, 
particularly in the context of low public understanding of 
dementia. The importance of better quality information 
about dementia (and the likelihood of developing 
dementia) and provision of psychological support for those 
undergoing risk assessment were highlighted.
IntrODuCtIOn 
Dementia has a huge impact on people 
living with the illness and their families and 
incurs substantial healthcare and societal 
costs; although more common in older popu-
lations, this impact may be greater when 
dementia occurs earlier in the life course 
and affects an individual’s ability to work and 
care for their family.1 Recent findings from 
large epidemiological studies have shown 
considerable inconsistencies in incidence 
and prevalence trends globally.2–4 A recent 
systematic review revealed that in high-in-
come countries the incidence and prevalence 
of dementia may be declining, probably due 
to health promotion activities on a wide 
scale; meanwhile in China and parts of Asia, 
figures are increasing possibly due to wors-
ening cardiovascular risk profiles.4 Although 
the evidence base around the medical, social 
and behavioural factors which influence 
dementia rates is increasing, this is a complex 
area.3 Notwithstanding, increasing evidence 
that dementia prevalence and incidence may 
be linked to large-scale, targeted vascular risk 
reduction and structured chronic illness care 
for diseases such as diabetes, in addition to 
increasing age,5 6 has led to a shift in global 
and national policy.7 8 In the absence of a 
strengths and limitations of this study
 ► Exploring public views on a clinical area where 
professionals struggle to achieve consensus poses 
considerable methodical challenges.
 ► Due to personnel changes, data analysis was 
conducted by different researchers from those who 
undertook data collection; this however facilitated a 
more critical stance to data interpretation.
 ► Data collection ceased due to time limitations on 
the study period; theoretically data collection should 
have continued until data saturation was achieved.
 ► Our study explored the perceptions of members of 
the public, none of whom had dementia; abstract 
views towards proactive approaches may change if 
personally facing such assessments.
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cure, reducing future dementia burden and costs may be 
best achieved by greater emphasis on prevention which 
aims to decrease the future number of people developing 
the illness.7 Although general population screening for 
dementia is not currently advocated,9 identifying groups 
at high risk of developing dementia and giving tailored 
advice to reduce individual risk, has been recommended 
by WHO10 as a cost-effective strategy to reduce the global 
burden of dementia.7 
This policy shift has resulted in initiatives such as 
targeted case finding,11 12 opportunistic assessment to 
identity possible signs of dementia in patients at high risk, 
for example, older people aged over 75 years; those with a 
predisposing medical condition, for example, Parkinson’s 
disease; very high vascular risk in middle age and younger 
adults (ie, post head injury or Down's syndrome).13 14 
However such schemes have being introduced into prac-
tice although with little evidence of effectiveness. In addi-
tion this has led to a growing research focus on developing 
feasible and valid risk assessment tools to determine, and 
quantify, a person’s risk of developing dementia, with the 
aim of identifying those who may best benefit from early 
intervention.15 Despite the development of new dementia 
risk assessment tools,16–18 there has been limited research 
evaluating their acceptability to patients, the public 
and healthcare professionals.19 A systematic review of 
attitudes to population screening for dementia recom-
mended further qualitative research to explore public 
and healthcare professional attitudes towards proactive 
approaches to dementia identification in greater depth.20 
Determining the barriers and facilitators to the use of 
dementia risk tools in routine practice is as important as 
ascertaining their validity.16 The aim of this study was to 
critically explore, using qualitative methods, the views of 
members of the public about the acceptability and feasi-
bility of proactive approaches to earlier diagnosis and 
identification of people at high risk of dementia.
MethODs
We anticipated that levels of knowledge about approaches 
to earlier identification of dementia and risk assessment 
among the general public would be low and therefore 
used task group methodology.21 22 Data collection in task 
groups is similar to focus group methodology but includes 
the presentation of evidence and information about the 
topic under discussion.
The content and format of the task group are 
summarised in box 1. The presentations, developed from 
recent literature reviews, aimed to provide a summary of 
evidence-based information in a lay format to facilitate 
informed discussion. A pilot task group was facilitated by 
CD, LN and LR with staff from Newcastle University with 
no specific expertise in dementia and refined prior to 
the main study. A detailed checklist of methods using the 
consolidated criteria for qualitative research guidelines23 
is available in online supplementary file 1.
Participants were recruited from two local non-statu-
tory organisations: (1) Voice North, a forum for patient/
public involvement in research based in the North-East of 
England (http://www. voicenorth. org/) and (2) Age UK, 
a national voluntary organisation, with local branches, 
which provides services and support to older people 
(http://www. ageuk. org. uk).
The two organisations used different recruitment 
approaches: Voice North mailed study information 
to their members while Age UK advertised the study 
through posters at meetings of family carers. Both organ-
isations sought consent from interested participants to 
pass their contact details to the research team. Potential 
participants were sent further study information and then 
contacted by a researcher who described the study and 
answered any questions. Participants were assured that 
participation was voluntary and that they could withdraw 
at any time. Written informed consent was secured from 
participants prior to each task group.
Data collection and analysis
A further five task groups, facilitated by CD and LN 
occurred between December 2015 and July 2016, each 
lasting approximately 2 hours. Four were held at Newcastle 
University and the fifth at an Age UK carers’ group. All 
task groups, including the pilot, were digitally recorded 
and transcribed verbatim; transcripts were checked and 
anonymised.
A thematic approach to analysis was adopted.24 Initially 
individual researchers read and reread one or two 
transcripts in detail to become familiar with the data. 
This stage was particularly important since changes 
of personnel meant that the analysis was conducted by 
different researchers (CB, EM, LP) to those facilitating 
box 1 task group content and format
1. Pretask group questionnaire (participant demographic details; 
personal experience of dementia; knowledge about dementia risk 
factors).
2. Presentation 1: Dementia assessment and diagnosis
 – Introduction to dementia and the process of diagnostic 
assessment: ‘facts and figures’— numbers living with dementia; 
knowledge to date regarding cause; clinical presentation; 
dementia subtypes; clinical assessment processes.
 – Case finding in high-risk groups; factors contributing to dementia; 
groups at high risk; proactive methods for earlier detection of 
dementia, for example, case finding.
3. Group discussion 1
4. Presentation 2: Dementia prevention and risk assessment
 – Risk assessment—risk factors for dementia.
 – Risk assessment tools—general process of disease risk 
assessment and risk assessment tools; specific dementia risk 
assessment tools.
 – Genetic screening and potential future treatments, for example, 
drugs/vaccines.
5. Group discussion 2
6. Posttask group questionnaire (knowledge about dementia risk 
factors).
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the task groups (CD, LN). The researchers noted areas 
of interest and potential codes independently and then 
compared ideas and discussed the data in workshops.
Following discussion of emergent themes, we devel-
oped separate coding frames for facilitator presentations 
and group discussions to avoid imposing ideas from the 
presentations onto participant data. These were then 
applied to further transcripts and discussed collectively 
in a further data workshop. Once the coding frames had 
been agreed, they were applied to all transcripts using 
Nvivo V.11. Output relating to each theme and subtheme 
was then reviewed and a narrative summary produced 
independently (by CB, EM, LP). This was thought to be 
a more effective way of scrutinising codes than simply 
checking coding or having two researchers code the 
data. The narratives were then compared and discussed 
in further data workshops. Finally a combined narrative 
was produced for each theme which incorporated the 
insights and perspectives of different researchers. In a 
final stage, each transcript was reread in conjunction with 
the narrative to identify any missing data or issues that 
had not been captured.
Quotations indicate the focus group (numbered FG1 to 
FG6), unique participant identifier and gender.
results
Of the 54 people invited to take part, 31 agreed to partic-
ipate in a task group; six groups were completed, each 
with between three and seven participants. The majority 
of participants were female (n=21, 68%). Around half 
the sample (n=15, 48%) was aged between 60 years and 
69 years; 13 (42%) were between 40 years and 59 years 
and 3 (10%) were 70+ years. Eighteen (58%) knew family 
members or friends with dementia; a small number had 
personal experience of proactive approaches to identi-
fying dementia.
Four overarching themes were identified, each of which 
had several subthemes (box 2). A key theme related to 
confusion around dementia and proactive approaches. 
Other themes related to views on proactive approaches, 
how these might be enacted in practice and alternative 
approaches that could potentially facilitate the early 
detection of dementia or reduce risk at a population level.
Confusion around dementia and proactive approaches
Throughout the task groups there was evidence of limited 
understanding of dementia and difficulties in distin-
guishing between approaches such as case finding in 
high-risk groups, risk assessment and genetic screening. 
We therefore use the generic term ‘proactive approaches’ 
for all of these activities and only differentiate between 
them where participants were clearly discussing a specific 
approach. Examples of confusion are illustrated in box 3 
and described below.
limited understanding of dementia
Participants’ understanding of dementia varied, even 
among those with personal experience of the illness. 
Uncertainty was expressed about the illness trajectory; 
boundaries between age-related memory decline, mild 
cognitive impairment and dementia; and the relationship 
box 2 Overview of themes and subthemes
Confusion around dementia and proactive approaches
 ► Limited understandings of dementia.
 ► Making sense of proactive approaches.
Views on proactive approaches to dementia
 ► Perceived benefits and limitations of proactive approaches.
 ► Psychological consequences of proactive approaches.
Practical issues in enacting proactive approaches to 
dementia
 ► Existing and potential new opportunities for implementation.
 ► Barriers to implementation of proactive approaches.
 ► Ethical considerations.
Alternatives to proactive approaches to dementia
 ► Raising awareness of dementia across the life course.
 ► Health promotion: policy and practice initiatives.
box 3 Confusion around dementia and proactive 
approaches
limited understanding of dementia
‘Now I don’t know to what degree you suffer Alzheimer’s, can you get 
milder cases, more severe cases? Do people just amble along with 
mild cases of dementia?’ (FG3, P17, female)
‘Then you say ‘dementia’, what do you mean? I know that’s stupid but 
my partner’s got mild cognitive impairment which could be classified 
as dementia, because he’s got memory problems, or it might be mild 
cognitive impairment, which is it?’ (FG2, P5, female)
‘Dementia as far as I’m aware, dementia is one form of Alzheimer’s 
disease’ (FG2, P6, male)
‘I think language is very powerful. You know, when I was younger, 
people who had memory problems, do you know, they were a bit 
wandered you know, they were just getting a bit worn out, you know. 
The language was kind, but, you talk about dementia, dementia, 
demented, crazy, and that, that, that encourages people to flee from it, 
to conceal it and not to share it- ‘(FG2, P10, male)
Making sense of proactive approaches
‘Does it not smack a bit of Big Brother if you're having a register? 'This 
person is going to get dementia. This person is going to get dementia. 
This person isn't.' It smacks of Big Brother sort of…’ (FG5, P24, male)
‘I don’t really know what genetic testing amounts to. It was mooted 
to me once because I’ve got an eye condition and it might be genetic, 
that it was possible to have that done. I was advised that it’s quite a 
big process to go through and it might not give you anything clear at 
the end of the day.' (FG6, P31, male)
‘I mean you really can't prove that if you're like say - do more 
exercise, change your diet and all that, will it stop you getting that?’ 
(FG3, P14, male)
‘And then it (health check) came back with a letter, with a big long 
‘score this for this, and this for that’ but it didn’t explain what those 
numbers meant.’ (FG1. P4, female)
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between dementia and specific subtypes, for example, 
Alzheimer’s disease (box 3).
All task groups discussed the stigma surrounding 
dementia which was thought to contribute to the lack of 
understanding of the condition and a reluctance to be 
open about symptoms. The fear of dementia was linked 
to the absence of a cure, potential loss of personhood 
and devastating effects of advanced dementia which were 
often conveyed through the language used when talking 
about people with dementia. Nevertheless many partic-
ipants felt that societal attitudes towards dementia were 
improving and drew parallels with other once stigma-
tising conditions, such as cancer.
Making sense of proactive approaches
Discussion around specific proactive approaches—case 
finding, risk assessment and genetic screening —revealed 
that participants often confused the different methods, 
sometimes attributing consequences to one approach 
which related to another. For example, while risk reduc-
tion behaviour could reduce the number of people with 
dementia, case finding would have no impact on prev-
alence. This distinction was not, however, understood 
by participants. Participants also voiced opinions which 
suggested a lack of understanding of specific methods. 
For example, one participant seemed to think that the 
case finding method would result in the clear identifica-
tion of individuals who were going to develop dementia 
in the future, rather than on identifying those with known 
risk factors (box 3).
The role of genes in dementia similarly seemed to 
be widely misunderstood by participants. While several 
participants suggested that genetic screening was the 
most useful of the proactive approaches, their comments 
seemed to be based on an implicit assumption that a 
definitive genetic test is available. Few participants seemed 
to have understood that a deterministic genetic test is 
currently only relevant to a small number of individuals 
with Alzheimer’s disease. Although this information was 
included in the presentation, it did not seem to have been 
understood by participants many of whom perceived risk 
of dementia to be largely determined by their personal 
family history. One participant, who had previously 
discussed genetic screening in relation to another condi-
tion, seemed more aware of the nuanced nature of the 
information, highlighting the value of personal experi-
ence in understanding the issues.
There was a widespread tendency for many partici-
pants to see the proactive approaches as providing more 
definitive information than is the case. The uncertainties 
surrounding proactive approaches were challenging for 
many participants and the importance of help with inter-
preting information about risk and how to act on it were 
stressed.
Views on proactive approaches to dementia
Despite their confusion about dementia and proactive 
approaches, several participants expressed generally posi-
tive views towards the concept of proactive approaches, 
such as ‘the earlier the diagnosis the better’, without artic-
ulating any specific benefits of different methods. Some 
participants valued general information on risk reduction 
but not detailed information about their personal risk of 
developing dementia. Only one participant commented 
that attitudes to proactive approaches in the abstract 
might change if personally faced with such approaches. 
In light of varied individual preferences one participant 
box 4 Views on proactive approaches
General views on proactive approaches
‘I don’t want to know that I might be going to get it. I don’t mind being 
told that, ‘If you do this, this and this you’re less likely to have it’, just 
as with heart disease or anything like that.’ (FG3, P11, female)
‘But perhaps you need different ways, different tools, because what 
we seem to be saying is that different things suit different people.’ 
(FG2, P9, female)
Perceived benefits and limitations of proactive approaches
‘But I think the point here is if you’ve got high cholesterol there’s a 
blood test that shows that and the doctor can do something about it. 
If you’re going to develop dementia it’s no good telling me unless you 
can cure it, I can do something myself about it or you can help me.’ 
(FG3, P16, male)
‘If there's medication which can slow it down, delay it or whatever and 
I could have that medication I would be silly to not have it.’ (FG5, P27, 
female)
‘…with dementia, I think I would like to know so I could get my life 
ironed out for my kids, because I wouldn't like to leave them in dire 
straits.’ (FG4, P22, female)
‘I think an early diagnosis might be quite frightening at the time but I 
think it’s only fair on your family so that they know what’s happening 
for you and for them to prepare themselves as well for what might 
happen, if they would be prepared to look after you or if they feel you 
might need to go into care’ (FG3, P17, female)
‘The majority of people will say, 'It will never happen to me anyway. 
I don’t need that test. I only smoke 20 fags a day and my neighbour 
smokes 30 so he’s far more likely to…’ (FG3, P16, male)
‘You can choose to ignore it, but you’ve been given the information 
and it’s your choice what you do with it, whereas at the minute, it’s not 
there.’
(FG6, P30, female)
Psychological consequences of proactive approaches
‘But there was no sign of it (dementia) in my brain at all. Now I think 
that was fantastic. I now know that there was no sign of it and that's 
really, really reassuring.’ (FG5, P23, female)
‘Do I really want to have the worry about me? It may happen. If I had 
symptoms of it, then like yourself I would go and probably find out. But 
I don't feel like I've got symptoms of it, so I don't really want to know 
that I could have it when I haven't got it, when I feel…’ (FG5, P28, 
female)
‘I think there are a percentage of people who wouldn't want to know 
because they're so scared of the diagnosis because they've seen what 
happens to people. They've seen relatives go into nursing homes and 
the eventual outcome.’ (FG6, P29, female)
‘I did some of these cognitive tests on the internet and I got myself 
really upset and stressed when I thought I wasn’t hitting the time 
allowed. I dropped out of that because I felt under pressure.’ (FG3, 
P17, female)
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suggested that individuals should be provided with a 
range of options (box 4).
Perceived benefits and limitations of proactive approaches to 
dementia
While some participants questioned the value of proactive 
approaches for a condition for which no cure was avail-
able, others valued the possibility of reducing risk and/or 
accessing disease-slowing treatment (box 4). Early diag-
nosis and, to a lesser extent, information on risk were also 
thought to facilitate planning for the future, both for the 
individual affected and—often more importantly—their 
families. Participants acknowledged that a significant 
limitation of proactive approaches was the fact that infor-
mation did not automatically result in behaviour change. 
Regardless of whether or not individuals chose to act on 
risk information, some participants felt that providing 
such information increased individual choice.
Psychological consequences of proactive approaches
Views on the psychological consequences of proactive 
approaches varied. Participants who had undergone 
either formal or informal assessment for memory prob-
lems described their relief on finding that they did not 
have dementia; others felt that even receiving a diagnosis 
of dementia could be a relief. In contrast, other partic-
ipants felt that proactive approaches while they were 
asymptomatic (eg, genetic screening, risk assessment) 
could create considerable anxiety (box 4).
Perceptions of dementia were thought to influence 
the psychological consequences of proactive approaches; 
participants felt that people who associated dementia with 
advanced disease would be afraid of finding out that they 
were at risk or had a diagnosis of dementia. While discus-
sions focused primarily on the psychological impacts of 
being given information about risk or possible diagnosis 
of dementia, the potential of proactive approaches to 
generate stress and anxiety was also highlighted.
Practical issues in enacting proactive approaches
This theme explores the suggestions made by participants 
about how proactive approaches might be integrated into 
practice and the challenges and questions this may raise.
existing and potential new opportunities for implementation
The most common suggestion for introducing proac-
tive approaches was to embed them in routine health 
check-ups, for example, the annual health review of 
older adults. Since this approach would focus only on 
people over a certain age, and dementia can occur in 
younger adults (eg, those with learning disabilities), 
routine risk assessments for younger adults, especially 
those at high risk, were also suggested. This was seen 
as preferable to introducing a new approach focusing 
exclusively on dementia and thought by participants to 
‘normalise’ the inclusion of potentially anxiety-provoking 
questions concerning memory loss (box 5). To address 
rising general practitioner (GP) workload and finan-
cial pressures on services, participants suggested that 
box 5 existing and potential new opportunities for 
implementation
existing and potential new opportunities for 
implementation
‘My doctors have started to do an annual review of people, so on their 
birthday they call you in, you go and see the practice nurse and they give 
you an Ministry of Transport annual car test (MOT) certificate, basically. So 
it could be at that point that if memory things were introduced to that kind 
of review… That’s just a standard thing so everybody understands that 
they’re going to go through that test, or whatever, then I think incorporating 
in that could help.’ (FG3, P11, female)
‘So you could have that health check on all those things, the blood 
pressure and if that regardless of age, so you don't have to hit the 60 box, 
if that health check put you in those risk factors then there's follow-up and 
questions asked about memory’ (FG4, P20, female)
‘You can go into your doctor’s surgery and you don’t necessarily have to 
see a doctor now do you? No, you’re seeing a practice nurse. It could be 
at that level that the tests are done and the risks are quoted to you. Then 
if you felt that you needed to see a doctor to explain it more or to give you 
better information…’ (FG3, P16, male)
‘I think rather than saying, ‘Oh, go to the GPs.’ I haven't been there for 
3 years and I don't need to go there now. Things popping up, but things 
more widespread across the community so that people will come 
across them more frequently. In what shape or form, I suppose that's 
debateable’ (FG6, P31, male)
barriers to implementing proactive approaches
‘It's getting appointments to see them, that's the problem. From personal 
experience, trying to get to see a GP, you just give up.’  
(FG6, P31, male)
‘They’re too busy. You know, you don't get enough time to do anything 
like that in my GP's surgery. You never, ever get it, because you don't 
get enough minutes' appointment.’ (FG1, P4, female)
‘There's none of the continuity like when you were smaller; we had a 
family doctor who was there for everybody's health for 50 years.’ (FG5, 
P27, female)
‘I do tend to try and- well, I do think I tell the truth in these 
questionnaires. But you may think, you've got a different idea, perhaps, 
than somebody else. You might under-exaggerate, or over-exaggerate. 
You think you're telling the truth, but actually…’  
(FG1, P1, female)
‘People with dementia, in the early stages, will hide the fact that 
they’ve got a problem and can sometimes fool quite a lot of people a 
lot of the time.’ (FG3, P11, female)
‘It also requires people to have insight into their memory problem and 
often people just haven’t, have they?’ (FG2, P9, female)
ethical considerations
‘As long as it’s an informed consent, but, I think, often [patients] will 
go with what the GP says because they trust their GP so it’s a big 
responsibility.’ (FG2, P5, female)
‘You're going to get a lot of people who will go to the GP for a 
completely different reason and the GP might turn round and say, ‘Do 
you think you have a memory problem?’ You think, ‘Well, I've come 
about my in-growing toenail. No, I don't. I'm not here about that.'’ 
(FG6, P29, female)
‘I think you would need counselling (…) yes, but then the whole thing 
and then it hits you on an emotional level and that’s what you need 
help.’ (FG2, P8, female)
‘If you are going to put yourself forward to identify your risk of 
dementia, then you want to know what will happen if you are at high 
Continued
 o
n
 3 Septem
ber 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2017-018677 on 3 February 2018. Downloaded from 
6 Robinson L, et al. BMJ Open 2018;8:e018677. doi:10.1136/bmjopen-2017-018677
Open Access 
self-completion questionnaires linked to patient records 
could be used or that other members of the primary care 
team could be involved. A few participants suggested that 
alternative venues such as community centres or health 
buses, would offer more relaxed environments for proac-
tive approaches.
barriers to implementation of proactive approaches
Participants identified three main barriers to imple-
menting a proactive approach in primary care: access 
to GPs; a lack of continuity of care and the perceived 
reluctance of people with dementia to acknowledge 
their problems and seek help. Participants highlighted 
the difficulties in getting appointments with GPs and the 
limited time available within appointments. While partic-
ipants felt that discussing concerns about memory prob-
lems would be easier with a GP with whom they had an 
established relationship, many had experienced a lack of 
continuity of care (box 5).
In addition to these problems, a number of barriers 
to early diagnosis were identified. Participants suggested 
that people with dementia or memory problems might be 
reluctant to seek help and that even those seen by a GP 
might present themselves in ways which hid their difficul-
ties. Participants acknowledged the tendency to under-
estimate alcohol or cigarette consumption and thought 
that similar behaviour would apply to questions about 
memory. Concerns were also raised about the ability of 
people with memory problems to recognise their own 
difficulties. In light of these concerns, there was a general 
preference for ‘objective’ tests (ie, genetic or blood 
tests—which are not currently available) which did not 
rely on self-reported information.
ethical considerations
Participants identified a number of ethical issues relating 
to proactive approaches. Some felt that seeking consent 
prior to proactive approaches was essential to enable 
patients to make informed decisions and prevent distress. 
Participants felt that time and support were needed to 
ensure that patients fully understood the purpose, poten-
tial outcomes and implications of tests, and did not simply 
comply with any questions asked by their GP. Particular 
concerns were raised about the case-finding approach 
and how this would be integrated into routine consulta-
tions (box 5).
Participants stressed the importance of providing 
appropriate support services (particularly for people 
with no close family and limited social networks) prior 
to introducing proactive approaches. One person with 
experience of genetic screening highlighted the need 
for emotional support during the process. A final ethical 
issue raised during the task groups was the possibility 
of increasing stigma towards individuals who developed 
dementia (regardless of whether or not they had taken 
steps to reduce the risk of developing the disease). This 
was particularly evident during some task groups in which 
participants spoke pejoratively about individuals who 
were perceived not to respond ‘appropriately’ to risk 
information.
Alternatives to proactive approaches
In addition to discussing integration of proactive 
approaches in primary care, participants suggested intro-
ducing approaches to target behaviour change at a popu-
lation level including increasing awareness of dementia 
and health promotion or policy initiatives to address risk 
factors.
raising awareness of dementia across the life course
Increasing awareness of dementia was seen as key to: 
reducing stigma; improving integration of people with 
dementia; and encouraging people to seek help at an 
earlier stage. Although awareness raising was discussed 
in all but one of the task groups, the emphasis varied 
markedly between groups. Awareness raising was gener-
ally seen as relevant to the entire population. Existing 
UK initiatives such as Dementia Friends25 and the Prime 
Minister’s Challenge26 were viewed positively (box 6).
Initiatives to raise dementia awareness among specific 
groups including older people and children were 
discussed by some groups. Some participants felt that 
including children was essential to effect a societal 
change, others argued against targeting younger gener-
ations either to avoid burdening them with information 
about dementia or because of perceptions that they were 
less likely to engage with an illness strongly related to 
older age.
Having accessible information presented by a cred-
ible source was key to awareness raising. One participant 
emphasised the importance of avoiding ‘medical jargon’ 
and presenting information that people could relate 
to. A range of existing opportunities for disseminating 
information were suggested including information in GP 
surgeries, community centres and patient participation 
groups.
health promotion: policy and practice initiatives
A number of aspects of health promotion were discussed 
by participants including the extent to which demen-
tia-specific advice was needed and the most appropriate 
age group to target. There was a general consensus 
that health promotion should not focus specifically 
on dementia, but prioritise a healthy lifestyle. As with 
box 5 Continued
risk of dementia. What services are out there, what’s the support, 
available and if there’s nothing available for you, you might think, ‘Well, 
what’s the point of knowing.'’ (FG2, P9, female)
'There's always going to be a percentage of the population, it's 
whether it's to do with health, whether it's to do with whatever, who 
just don't give a s***. But also - but that impacts on us, because 
eventually we're going to have to pay for the people who don't give a 
s***.' (FG4, P20, female)
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awareness raising, views differed over whether health 
promotion campaigns should target children and the 
role of schools in promoting a healthy lifestyle (box 5).
Support at a government level was clearly relevant to 
both awareness raising and health promotion. However, 
concerns over the lack of reach of these types of initiatives, 
led some participants to suggest that policy changes might 
be more effective. Taking certain foods or enforcing limits 
on the food industry were most frequently suggested as 
ways of ‘enforcing’ a healthier lifestyle. While the former 
was welcomed by some, others were concerned about 
the potential loss of individual freedom. Concerns were 
expressed about frequently changing advice on healthy 
diet and lifestyle since this created uncertainties over how 
to act on such information and potentially undermined 
the potential value of both health promotion and 
providing risk information.
DIsCussIOn
Although presentations were embedded within each task 
group to introduce dementia case finding, dementia 
risk assessment and genetic screening, these were insuf-
ficient to ensure that participants fully understood the 
key concepts. They were, however, able to comment 
on the general principles underlying earlier diagnosis 
and risk assessment for dementia. Earlier diagnosis was 
generally welcomed by all participants but views varied 
regarding risk assessment and genetic screening prior 
to the emergence of symptoms. There was a preference 
to embed risk assessment within routine health checks, 
which focused on achieving a healthier lifestyle, rather 
focusing specifically on dementia. Participants felt that 
such health checks should be more widely available and 
provided by a range of health professionals, including 
nurses. They also emphasised the need to explore prefer-
ences and ensure individuals understand what is involved 
prior to introducing proactive approaches into routine 
practice. The confusion evident during the task groups 
confirms the importance of providing accessible informa-
tion to enable people to make informed decisions. While 
participants expressed a strong preference for objec-
tive measures rather than those relying on self-reported 
behaviour, this is at odds with the types of risk assessment 
tools currently available. Although participants also spoke 
positively about the need for population approaches to 
promoting healthy lifestyles, some recognised the poten-
tial for negative consequences for individuals who did not 
adopt recommended lifestyle changes.
The confusion among our public participants around 
dementia as a condition, and approaches to its earlier iden-
tification, is unsurprising in an area where professionals 
themselves struggle to achieve consensus27 28 and expert 
diagnostic classifications change.29 However in terms of 
public attitudes towards earlier diagnosis of dementia, our 
findings mirror a systematic review which found that both 
people with and without cognitive impairment wanted 
to know sooner, rather than later, if they had dementia 
in order to better prepare for their future.30 Notwith-
standing one of the key challenges around introducing 
approaches to the earlier identification of people with 
dementia, and also those at higher risk, is a continuing 
professional stigma around using the diagnostic label 
of dementia and opening saying the D word to patients 
despite increasing public awareness campaigns.31 Varia-
tions in international clinical practice around the use of 
mild cognitive impairment as a diagnostic label further 
increase professional inconsistencies.32
In terms of identifying those at higher risk of devel-
oping dementia, it is interesting to note our partici-
pants’ preference for such approaches to be part of an 
integrated, holistic approach to maintaining health in 
mid/later life rather than dementia-specific initiatives. 
box 6 Alternatives to proactive approaches
raising awareness of dementia across the life course
‘I mean, the dementia friends thing (…) if you can get everybody, you 
can get kids at school to understand how they can best talk to Granny, 
how they can react to somebody in the street who is wandering or 
who’s talking to themselves, how to be nice to the person, how to 
support them.’ (FG2, P7, female)
‘I think acceptance of it, even it was part of primary/secondary, 
actually getting it in the schools and getting it at that young age to 
understand that they're not that person. It's just part of a condition 
they've got, and acceptance.’ (FG6, P30, female)
‘Having taught in an further education (FE) college and taught health 
and social care subjects, 16 to 19 year olds think they're going to live 
forever. When you try to talk to them about smoking and drinking, 
it's just over the top of their head. I don't know. Even if they've had 
experience of grandparents with dementia they think, "It's never going 
to happen to me and I'm going to live forever and who cares what 
happens to me when I get to 65?"’ (FG6, P29, female)
health promotion: policy and practice initiatives
‘There's a general advice there that's not specific to dementia (…) 
there's a generic thing going on about ‘well if you want to keep your 
heart going, you need to give up smoking’. It's the same things. So 
maybe we need to actually pull dementia or the risks of dementia into 
that general health and well-being better than perhaps we're currently 
doing.’ (FG4, P19, male)
‘The schools have enough on their plate with directives coming to say, 
‘You must teach X amount of maths, English and science’ and that’s 
push, push, push. They don’t leave a lot of time. They’ve taken less 
physical education (PE). So schools don’t have that facility’ (FG3, P12, 
female)
‘Not everybody is going to get that education, not everybody is going 
to listen to that education. And there's parental influence on it, social 
influence on it, economic influence on it. So I think you've got sort of 
- I believe very strongly in personal choice, but I think there's a point 
where you've got to look at it more on a sort of society level.’ (FG4, 
P18, male)
With healthy eating, at least now they’re going to put this sugar tax on, 
but I would put tax on a load of other things like that. (FG3, P14, male)
‘The trouble is with these diets, again, you get it in the papers, ‘Don't 
drink tea, because it's got this… Don't drink coffee because it's got 
that.’ And then a few months down the line, ‘Oh, tea's good for you. 
Coffee is good for you.’ What do you believe?’ (FG4, P22, female)
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Such results lend support to current research evalu-
ating holistic health and well-being risk appraisal tools.33 
Earlier qualitative research exploring public knowledge 
of dementia risk factors and views on risk reduction 
approaches found reasonably good knowledge of factors 
which contribute to healthy ageing.19 Interestingly fear 
of developing dementia, and the need to improve public 
knowledge about dementia, were considered major moti-
vators among participants towards adopting a healthier 
lifestyle and improved health behaviours.19
Our qualitative study had several limitations. Data 
collection ceased due to time limitations on the study 
period; theoretically data collection should have 
continued until data saturation was achieved. This study 
explored the perceptions of members of the public, none 
of whom had dementia. The focus was therefore on case 
finding, risk assessment/reduction and genetic screening 
as abstract concepts; participants’ views may differ when 
facing such activities at a personal level. The limited 
public understanding of dementia34 was confirmed in 
the present study. This suggests that future studies may 
need to consider either focusing on a single proactive 
approach (eg, genetic screening) to avoid introducing 
multiple concepts, or that data collection may need to be 
conducted over a longer period to enable participants to 
become familiar with the concepts and facilitate informed 
discussions, for example, through citizens’ juries.35 Due 
to personnel changes, data analysis was conducted by 
researchers who had no previous involvement in the 
project. However, as the researchers were more distant 
from the data, this facilitated a more critical stance and 
the identification of underlying themes indirectly linked 
with the study objective.
Recent data on the changing incidence and prev-
alence of dementia internationally4 have generated 
research interest in prevention through controlling risk 
factors at both individual and population levels.36 While 
interim findings from a randomised controlled trial of 
a complex, multicomponent intervention (diet, phys-
ical exercise, brain training, vascular risk reduction) 
targeting individual dementia risk have revealed prom-
ising results,37 the search for feasible and valid risk 
assessment ‘tools’ to identify those who would benefit 
most from such interventions is ongoing.15 There has 
however been little exploration of the acceptability 
of such approaches to patients and the public19 espe-
cially in dementia where public understanding of the 
illness is still low.34 With electronic vascular disease risk 
assessment tools such as Q-RISK2, which allow health-
care professionals to quickly calculate an individual’s 
future risk,38 39 now embedded in routine primary care 
practice, similar methods have been used to develop a 
dementia risk tool.16 The validity of this tool is currently 
under study, it will however be equally important to 
also explore its acceptability to patients and healthcare 
professionals, especially if considering the possibility of 
patient self-administered tools in the future.40 In terms 
of the implications for practice, our study shows that 
the introduction of proactive approaches to dementia 
identification should also be accompanied by better 
quality information about dementia (and the likelihood 
of developing dementia) and psychological support for 
those undergoing risk assessment as well as addressing 
important public concerns about the quality and avail-
ability of current dementia care.
As international policy shifts from finding a ‘cure’ for 
dementia to focus on more efficient ways of future care 
provision, including reducing numbers with dementia, 
research opportunities are beginning to address the 
prevention as well as ‘cure and care’ agenda.36 41 Accu-
rate identification of an individual’s risk of developing 
dementia, in order to identify those who can most benefit 
from appropriate intervention, will be one part of this 
new agenda; any future research must however also 
explore the ethical and personal concerns associated 
with any newly developed approaches to determining an 
individual’s future risk of developing dementia. While the 
usefulness and efficiency of general lifestyle checks have 
been questioned,42 these may be a more acceptable way 
of translating dementia risk reduction approaches into 
usual care. The considerable confusion among our partic-
ipants around approaches to earlier identification of both 
people with possible dementia and those at higher risk 
of developing the illness in the future suggests an urgent 
need for greater education focused on dementia risk and 
individual risk reduction.
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